Enhanced angioplasty with focal force technology now offers a proven path to achieving more effective and durable results.

Okami Medical, Inc., a developer of vascular embolization solutions, announced that Drew Hykes was appointed President and ...

Pathfinder Medical, a United Kingdom-based developer of minimally invasive vascular access technologies, announced the appoint ...

CAS plus intensive medical therapy significantly reduced 4-year stroke or death rates compared with medical therapy alone. CEA did not provide a significant additional benefit over intensive medical ...

November 19, 2025—Gore & Associates and Egg Medical announced findings from a national poll on the concerns regarding radiation exposure in operating rooms and catheterization labs across the country.

November 17, 2025—Surmodics, Inc. announced that it expects to close promptly the previously announced acquisition (“merger”) of the company by an affiliate of GTCR LLC. In May 2024, the company ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

We value keeping the Device Guide up to date.